Randal W. Scott

Chief Executive Officer, Genomic Health.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • May 15, 2026Sold 200 shares at $69.12 of BridgeBio9
  • May 15, 2026Sold 1,512 shares at $68.23 of BridgeBio9
  • May 15, 2026Sold 2,088 shares at $67.53 of BridgeBio9
  • May 15, 2026Sold 6,200 shares at $66.69 of BridgeBio9
  • May 15, 2026Exercised options 10,000 shares at $16.75 of BridgeBio9
  • Feb 17, 2026Sold 3,307 shares at $75.93 of BridgeBio11
  • Feb 17, 2026Sold 4,793 shares at $75.57 of BridgeBio11
  • Feb 17, 2026Sold 1,900 shares at $74.34 of BridgeBio11
  • Feb 17, 2026Exercised options 10,000 shares at $16.75 of BridgeBio11
  • Nov 17, 2025Sold 6,199 shares at $66.89 of BridgeBio12
  • Nov 17, 2025Sold 3,801 shares at $66.25 of BridgeBio12
  • Nov 17, 2025Exercised options 10,000 shares at $16.75 of BridgeBio12
  • Jun 20, 2025Granted 6,589 shares of BridgeBio13
  • Jun 4, 2024Sold 1,500 shares at $31.30 of BridgeBio14
  • Jun 3, 2024Sold 200 shares at $29.48 of BridgeBio14
  • Jun 3, 2024Sold 800 shares at $28.68 of BridgeBio14
  • Mar 1, 2024Sold 2,500 shares at $34.00 of BridgeBio15
  • Dec 18, 2023Sold 2,000 shares at $40.00 of BridgeBio16
  • Dec 1, 2023Sold 1,500 shares at $30.00 of BridgeBio17
  • Dec 1, 2023Sold 1,000 shares at $28.50 of BridgeBio17
  • Sep 5, 2023Sold 2,500 shares at $30.00 of BridgeBio18
  • Apr 27, 2023Granted 70,422 shares of Invitae10
  • Jul 16, 2022Granted 8,475 shares of Invitae19
  • Jul 16, 2022Granted 45,325 shares of Invitae19